Secondary Mutations at I1171 in the ALK Gene Confer Resistance to Both Crizotinib and Alectinib

被引：68

作者：

Toyokawa, Gouji ^{[1
]}

Hirai, Fumihiko ^{[1
]}

Inamasu, Eiko ^{[1
]}

Yoshida, Tsukihisa ^{[1
]}

Nosaki, Kaname ^{[1
]}

Takenaka, Tomoyoshi ^{[1
]}

Yamaguchi, Masafumi ^{[1
]}

Seto, Takashi ^{[1
]}

Takenoyama, Mitsuhiro ^{[1
]}

Ichinose, Yukito ^{[1
]}

机构：

[1] Kyushu Natl Canc Ctr, Dept Thorac Oncol, Fukuoka 8111395, Japan

来源：

JOURNAL OF THORACIC ONCOLOGY | 2014年 / 9卷 / 12期

基金：

日本学术振兴会;

关键词：

LUNG-CANCER; INHIBITORS; MUTANTS;

D O I：

10.1097/JTO.0000000000000358

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：E86 / E87

页数：2

共 8 条

[1] Treating ALK-positive lung cancer-early successes and future challenges [J].

Camidge, D. Ross ;

Doebele, Robert C. .

NATURE REVIEWS CLINICAL ONCOLOGY, 2012, 9 (05) :268-277

[2] Crizotinib-Resistant NPM-ALK Mutants Confer Differential Sensitivity to Unrelated Alk Inhibitors [J].

Ceccon, Monica ;

Mologni, Luca ;

Bisson, William ;

Scapozza, Leonardo ;

Gambacorti-Passerini, Carlo .

MOLECULAR CANCER RESEARCH, 2013, 11 (02) :122-132

[3] EML4-ALK Mutations in Lung Cancer That Confer Resistance to ALK Inhibitors [J].

Choi, Young Lim ;

Soda, Manabu ;

Yamashita, Yoshihiro ;

Ueno, Toshihide ;

Takashima, Junpei ;

Nakajima, Takahiro ;

Yatabe, Yasushi ;

Takeuchi, Kengo ;

Hamada, Toru ;

Haruta, Hidenori ;

Ishikawa, Yuichi ;

Kimura, Hideki ;

Mitsudomi, Tetsuya ;

Tanio, Yoshiro ;

Mano, Hiroyuki .

NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (18) :1734-1739

[4] The ALK Inhibitor Ceritinib Overcomes Crizotinib Resistance in Non-Small Cell Lung Cancer [J].

Friboulet, Luc ;

Li, Nanxin ;

Katayama, Ryohei ;

Lee, Christian C. ;

Gainor, Justin F. ;

Crystal, Adam S. ;

Michellys, Pierre-Yves ;

Awad, Mark M. ;

Yanagitani, Noriko ;

Kim, Sungjoon ;

Pferdekamper, AnneMarie C. ;

Li, Jie ;

Kasibhatla, Shailaja ;

Sun, Frank ;

Sun, Xiuying ;

Hua, Su ;

McNamara, Peter ;

Mahmood, Sidra ;

Lockerman, Elizabeth L. ;

Fujita, Naoya ;

Nishio, Makoto ;

Harris, Jennifer L. ;

Shaw, Alice T. ;

Engelman, Jeffrey A. .

CANCER DISCOVERY, 2014, 4 (06) :662-673

[5] Selective ALK inhibitor alectinib with potent antitumor activity in models of crizotinib resistance [J].

Kodama, Tatsushi ;

Tsukaguchi, Toshiyuki ;

Yoshida, Miyuki ;

Kondoh, Osamu ;

Sakamoto, Hiroshi .

CANCER LETTERS, 2014, 351 (02) :215-221

[6] Next-Generation Sequencing Reveals a Novel NSCLC ALK F1174V Mutation and Confirms ALK G1202R Mutation Confers High-Level Resistance to Alectinib (CH5424802/RO5424802) in ALK-Rearranged NSCLC Patients Who Progressed on Crizotinib [J].

Ou, Sai-Hong Ignatius ;

Azada, Michele ;

Hsiang, David J. ;

Herman, June M. ;

Kain, Tatiana S. ;

Siwak-Tapp, Christina ;

Casey, Cameron ;

He, Jie ;

Ali, Siraj M. ;

Klempner, Samuel J. ;

Miller, Vincent A. .

JOURNAL OF THORACIC ONCOLOGY, 2014, 9 (04) :549-553

[7] CH5424802, a Selective ALK Inhibitor Capable of Blocking the Resistant Gatekeeper Mutant [J].

Sakamoto, Hiroshi ;

Tsukaguchi, Toshiyuki ;

Hiroshima, Sayuri ;

Kodama, Tatsushi ;

Kobayashi, Takamitsu ;

Fukami, Takaaki A. ;

Oikawa, Nobuhiro ;

Tsukuda, Takuo ;

Ishii, Nobuya ;

Aoki, Yuko .

CANCER CELL, 2011, 19 (05) :679-690

[8] Crizotinib-Resistant Mutants of EML4-ALK Identified Through an Accelerated Mutagenesis Screen [J].

Zhang, Sen ;

Wang, Frank ;

Keats, Jeffrey ;

Zhu, Xiaotian ;

Ning, Yaoyu ;

Wardwell, Scott D. ;

Moran, Lauren ;

Mohemmad, Qurish K. ;

Anjum, Rana ;

Wang, Yihan ;

Narasimhan, Narayana I. ;

Dalgarno, David ;

Shakespeare, William C. ;

Miret, Juan J. ;

Clackson, Tim ;

Rivera, Victor M. .

CHEMICAL BIOLOGY & DRUG DESIGN, 2011, 78 (06) :999-1005

← 1 →